Variant Revenue and Competitors

Atlanta, GA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Variant's estimated annual revenue is currently $131.6M per year.(i)
  • Variant's estimated revenue per employee is $410,000

Employee Data

  • Variant has 321 Employees.(i)
  • Variant grew their employee count by 18% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M489%N/AN/A
#2
$2.8M140%N/AN/A
#3
$1.5M9-61%N/AN/A
#4
$94.9M2635%N/AN/A
#5
$25.3M774%N/AN/A
#6
$3.5M18N/AN/AN/A
#7
$1083.7M2360N/AN/AN/A
#8
$157.9M3855%N/AN/A
#9
$19.2M65-4%N/AN/A
#10
$33.1M1012%N/AN/A
Add Company

What Is Variant?

With our one-of-a-kind operating model, we are disrupting one of America's largest industries and putting drivers back in the driver's seat. Long haul trucking has needed an overhaul for a long time. It hasn't been working for drivers. And it hasn't been working for shippers either. Until now. We're reengineering trucking. For good.

keywords:N/A

N/A

Total Funding

321

Number of Employees

$131.6M

Revenue (est)

18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Variant News

2022-04-19 - Covid Whiplash: Now-Dominant BA.2 Variant Being Quickly Overtaken Across The U.S. By Yet Another Faster-Growing Omicron Offshoot, Says CDC

Covid Whiplash: Now-Dominant BA.2 Variant Being Quickly Overtaken Across The U.S. By Yet Another Faster-Growing Omicron Offshoot, BA.2.12.1.

2022-04-17 - COVID Reinfection Rate in NY County Hit Hard by Contagious Subvariant Is Nearly 3x Average

New COVID variant with the highest transmission rate yet is raising infection rates in New York, Kathy Hochul says.

2022-04-17 - New COVID variant? What is the ‘Frankenstein’ COVID variant?

The omicron XE variant continues to circulate throughout the country. Read about the omicron variant and the omicron COVID combination...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$101.5M3213%N/A
#2
$60.4M322-7%N/A
#3
$110.8M32313%$117M
#4
$35M3238%N/A
#5
$100.9M3238%N/A